Jessica L. Mega, MD, MPH, is the Chief Medical Officer at Verily Life Sciences. As CMO, Dr. Mega’s focus is on translating technological innovations and scientific insights into partnerships and programs that improve patient outcomes. She oversees all of Verily’s clinical and science efforts, including the Baseline Study. As a faculty member at Harvard Medical School, a senior investigator with the TIMI Study Group, and a cardiologist at Brigham and Women’s Hospital, she led large, international, randomized trials evaluating novel cardiovascular therapies. Dr. Mega is a graduate of Stanford University, Yale University School of Medicine and Harvard School of Public Health. She completed her Internal Medicine Residency at Brigham and Women’s Hospital and Cardiovascular Fellowship at Massachusetts General Hospital. She is board certified in Internal Medicine and Cardiology.
Unleashing the Power of Innovation on the Next Decade